[go: up one dir, main page]

GB0406598D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB0406598D0
GB0406598D0 GBGB0406598.3A GB0406598A GB0406598D0 GB 0406598 D0 GB0406598 D0 GB 0406598D0 GB 0406598 A GB0406598 A GB 0406598A GB 0406598 D0 GB0406598 D0 GB 0406598D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0406598.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Original Assignee
University of Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leicester filed Critical University of Leicester
Priority to GBGB0406598.3A priority Critical patent/GB0406598D0/en
Publication of GB0406598D0 publication Critical patent/GB0406598D0/en
Priority to PCT/GB2005/050032 priority patent/WO2005092371A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0406598.3A 2004-03-24 2004-03-24 Vaccine Ceased GB0406598D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0406598.3A GB0406598D0 (en) 2004-03-24 2004-03-24 Vaccine
PCT/GB2005/050032 WO2005092371A1 (en) 2004-03-24 2005-03-11 Hybrid cell vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0406598.3A GB0406598D0 (en) 2004-03-24 2004-03-24 Vaccine

Publications (1)

Publication Number Publication Date
GB0406598D0 true GB0406598D0 (en) 2004-04-28

Family

ID=32188591

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0406598.3A Ceased GB0406598D0 (en) 2004-03-24 2004-03-24 Vaccine

Country Status (2)

Country Link
GB (1) GB0406598D0 (en)
WO (1) WO2005092371A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070212338A1 (en) * 2000-01-11 2007-09-13 Greenville Hospital System Hybrid cells
IL292510A (en) * 2013-11-05 2022-06-01 Cognate Bioservices Inc Combinations of checkpoint inhibitors and cancer drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843004A (en) * 1984-05-11 1989-06-27 Sloan-Kettering Institute For Cancer Research Method for the production of human T-T cell hybrids and production suppressor factor by human T-T cell hybrids
AU2000236583A1 (en) * 2000-02-27 2001-09-03 Eberhard-Karls-Universitattubingen Universitatsklinikum Hybrid cell vaccines

Also Published As

Publication number Publication date
WO2005092371A1 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
TWI365191B (en) Vaccine
IL178890A0 (en) Vaccines
GB0922611D0 (en) Improved vaccines
IL192084A0 (en) Vaccine
GB0504436D0 (en) Vaccine
GB0409940D0 (en) Vaccine
GB0420634D0 (en) Vaccines
GB0411150D0 (en) Vaccine
ZA200709207B (en) Vaccine
GB0413510D0 (en) Vaccine
GB0810662D0 (en) Vaccine
GB0515135D0 (en) Vaccine
GB0412407D0 (en) Vaccine
GB0516944D0 (en) Vaccine
GB0428381D0 (en) Vaccine
GB0419918D0 (en) Vaccine
GB0406598D0 (en) Vaccine
AP2709A (en) An anti-theileriosis vaccine
GB0413513D0 (en) Vaccine
GB0412547D0 (en) Vaccine
GB0413154D0 (en) Vaccine
GB0425339D0 (en) Vaccine
GB0416833D0 (en) Vaccine
GB0413371D0 (en) Vaccine
GB0416398D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)